Louise F Hill

Clinical Lecturer in Paediatric Infectious Diseases

St George’s, University of London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Louise F Hill is a Clinical Lecturer in Paediatric Infectious Diseases at St George's University of London, UK. Her research focuses on safety reporting in neonatal clinical trials, optimized dosages of vancomycin for treating infections in infants, and rapid syndromic testing for acute respiratory infections in children. Recent articles reflect her commitment to advancing clinical practices and improving patient outcomes in paediatric care.

Articles (5)

Year:

2025

Year:

2024

Year:

2022

Year:

2021

Year:

2020

Collaborators (3)

Paul Heath

St. George's University

UNITED KINGDOM

View details

Tuuli Metsvaht

ESTONIA

View details

Michelle Clements

University College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Louise F Hill

Research Interests

Explore related searches

Contact this professor

About

Articles (5)

Safety reporting in neonatal clinical trials: reflections towards optimal, globally relevant approaches

Randomised multicentre effectiveness trial of rapid syndromic testing by panel assay in children presenting to European emergency departments with acute respiratory infections—trial protocol for the ADEQUATE Paediatric trial

Need for standardized vancomycin dosing for coagulase-negative staphylococci in hospitalized infants.

Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial.

An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial.

Collaborators (3)

Paul Heath

Tuuli Metsvaht

Michelle Clements

Make your next move.